Evidence map›Paper›PMID 37312219›Full record

ArticleJournal of orthopaedic surgery and research2023

Knockdown of circSOD2 ameliorates osteoarthritis progression via the miR-224-5p/PRDX3 axis.

Hao Li, Yong Cao, Chongfei Chang, Wenping Huang, Songchuan Su, Zhenggang Peng, Jiajin Zhang

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hao Li *Department of Sports Medicine, Shenzhen Second People's Hospital, Shenzhen, 518037, Guangdong, China.
Yong Cao *Department of Orthopaedic Emergency, Chongqing Orthopedic Hospital of Traditional Chinese Medicine, Chongqing, 400000, China.
Chongfei ChangShenzhen Cheerland Danlun Biomedical Co. Ltd, Shenzhen, 518108, Guangdong, China.
Wenping HuangDepartment of Traumatic Orthopedics, Chongqing Orthopedic Hospital of Traditional Chinese Medicine, 9 Jiefang West Road, Yuzhong District, Chongqing, 400000, China.
Songchuan SuDepartment of Traumatic Orthopedics, Chongqing Orthopedic Hospital of Traditional Chinese Medicine, 9 Jiefang West Road, Yuzhong District, Chongqing, 400000, China.
Zhenggang PengDepartment of Traumatic Orthopedics, Chongqing Orthopedic Hospital of Traditional Chinese Medicine, 9 Jiefang West Road, Yuzhong District, Chongqing, 400000, China.
Jiajin ZhangDepartment of Traumatic Orthopedics, Chongqing Orthopedic Hospital of Traditional Chinese Medicine, 9 Jiefang West Road, Yuzhong District, Chongqing, 400000, China. ghut112@sina.com.
First People's Hospital of Chongqing · CNKelun Group (China) · CNShenzhen Second People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough the implications of circular RNAs (circRNAs) with the progression of diverse pathological conditions have been reported, the circRNA players in osteoarthritis (OA) are barely studied.

methodsIn this study, twenty-five OA patients who received arthroplasty were recruited for cartilage tissue collection. Public circRNA microarray data from Gene Expression Omnibus was retrieved for circRNA identification. An in vitro cell model of OA-related damages was constructed by treating human chondrocytes (CHON-001 cell line) with IL-1β, and circSOD2 siRNA was used to silence circSOD2 expression to study its functional role in apoptosis, inflammatory responses, and extracellular matrix (ECM) degradation. Besides, we investigated the functional interactions among circSOD2, miR-224-5p, and peroxiredoxin 3 (PRDX3) by luciferase reporter assay, RNA-immunoprecipitation assay, and quantitative reverse transcription polymerase chain reaction.

resultsOur findings revealed the overexpression of circSOD2 in the OA cartilage and cell samples, and circSOD2 knockdown alleviated ECM degradation, inflammation, and apoptosis in CHON-001 cell model. In addition, our findings suggested the regulatory function of circSOD2 knockdown on miR-224-5p expression, while miR-224-5p was capable of downregulating PRDX3 expression. The co-transfection of miR-224-5p inhibitor or pcDNA-PRDX3 could prevent the effect of circSOD2 knockdown.

conclusionHence, our results demonstrated that knockdown of circSOD2 may serve as an intervention strategy to alleviate OA progression through modulating miR-224-5p/PRDX3 signaling axis.

Indexed as

MicroRNAsOsteoarthritisHumansPeroxiredoxin IIIRNA, CircularRNA, Small InterferingSuperoxide Dismutase 2MicroRNAsMIRN224 microRNA, humanPeroxiredoxin IIIPRDX3 protein, humanRNA, CircularRNA, Small InterferingSuperoxide Dismutase 2circSOD2miR-224-5pOAPRDX3

Identifiers

PMID37312219
PMCPMC10265860
OpenAlexW4380480674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.